Question:

Plasmid $pBR322$ has PstI restriction enzyme site within gene $a m p^{R}$ that confers ampicillin resistance. If this enzyme is used for inserting a gene for $\beta$-galactoside production and the recombinant plasmid is inserted in an E.coli strain

Updated On: Nov 13, 2025
  • it will not be able to confer ampicillin resistance to the host cell.
  • the transformed cells will have the ability to resist ampicillin as well as produce $\beta$-galactoside.
  • it will lead to lysis of host cell.
  • it will be able to produce a novel protein with dual ability.
Hide Solution
collegedunia
Verified By Collegedunia

The Correct Option is A

Solution and Explanation

The question involves understanding the function of the plasmid $pBR322$ and the effect of inserting a gene at a specific restriction site. Let's analyze the provided scenario step-by-step.

Step 1: Understanding the Background

Plasmid $pBR322$ is a common cloning vector in genetic engineering. It contains several important features:

  • Two antibiotic resistance genes: one for ampicillin resistance (am^{R}) and another for tetracycline resistance.
  • Multiple cloning sites that can be used to insert foreign DNA, including a site for the PstI restriction enzyme within the am^{R} gene.

Step 2: Recombinant DNA Technique

When the PstI restriction enzyme is used to cut the plasmid, the am^{R} gene is disrupted. This disruption means that if a foreign gene, such as the one coding for β-galactoside production, is inserted at this site, the plasmid is now a recombinant plasmid.

Step 3: Consequences of Disruption

When inserted into an E. coli strain, the recombinant plasmid results in the following:

  • The disruption of the am^{R} gene by the insertion means that the gene no longer functions as before, and the host cell cannot produce the enzyme needed to confer resistance to ampicillin.
  • As a result, the E. coli cell with the recombinant plasmid will not survive in an environment containing ampicillin because it has lost its resistance due to the insertional inactivation of the am^{R} gene.
  • The cell may produce the β-galactoside depending on the expression levels and activity of the inserted gene, but this does not influence ampicillin resistance.

Conclusion:

The correct answer is: it will not be able to confer ampicillin resistance to the host cell. Inserting the gene for β-galactoside production disrupts the function of the relevant resistance gene, thus preventing the recombinant cells from surviving in the presence of ampicillin.

Was this answer helpful?
0
0

Questions Asked in NEET exam

View More Questions

Concepts Used:

Recombinant Technology

Recombinant DNA technology is the process used for producing new genetic combinations by joining different genetic material (DNA) together and inserting them into host organisms from two different species or sources. These new combinations are of value to medicine, science, industry, and agriculture.

Process of Recombinant DNA Technology:

Step 1- Isolation of Genetic Material.

Step 2- Cutting the gene at the recognition sites.

Step 3- Amplifying the gene copies through Polymerase chain reaction ( PCR)

Step 4- Ligation of DNA Molecules.

Step 5- Insertion of Recombinant DNA into Host.

Application of Recombinant DNA Technology:

  • In agricultural fields Recombinant DNA Technology plays a major role. It produces genetically-modified organisms such as flavor save tomatoes, golden rice rich in protein and lot more
  • Recombinant DNA technology is also used to produce Insulin.
  • ELISA is one kind of clinical diagnosis where recombinant DNA technology is used.
  • Recombinant DNA technology prevents hereditary diseases through gene therapy and also detects the presence of HIV in a person.